Search Articles
WASHINGTON – The Food and Drug Administration properly approved Coastal Pharmaceuticals’ generic eye-drop drug, a federal judge ruled Monday, dismissing claims from ISTA Pharmaceuticals, which markets Xibrom and Bromday.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.